Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Loncar Cancer Immunotherapy ETF (CNCR)

Loncar Cancer Immunotherapy ETF (CNCR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Exchange Traded Concepts
  • Assets Under Management 20,489,000
  • Shares Outstanding, K 1,400
  • 60-Month Beta 0.96
Trade CNCR with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 1.85 (12.66%)
  • Most Recent Dividend 1.853 on 12/29/21
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.98 +4.69%
on 09/23/22
16.28 -10.10%
on 09/12/22
-0.96 (-6.17%)
since 09/02/22
3-Month
13.98 +4.69%
on 09/23/22
18.01 -18.74%
on 08/15/22
-0.86 (-5.57%)
since 07/01/22
52-Week
12.76 +14.69%
on 06/13/22
30.49 -52.00%
on 11/03/21
-15.92 (-52.10%)
since 10/01/21

Most Recent Stories

More News
The Zacks Analyst Blog Highlights BBC, CNCR XBI, BBP, and SBIO

BBC, CNCR, XBI, BBP, and SBIO are part of Zacks top Analyst Blog.

CNCR : 15.18 (+3.69%)
BBC : 25.34 (+3.34%)
XBI : 82.23 (+2.81%)
SBIO : 30.87 (+2.20%)
BBP : 47.15 (+2.02%)
5 ETFs Riding High on the Biotech Comeback

Biotech, the downtrodden segment of the market, has made a solid comeback on bargain hunting.

CNCR : 15.18 (+3.69%)
BBC : 25.34 (+3.34%)
XBI : 82.23 (+2.81%)
SBIO : 30.87 (+2.20%)
BBP : 47.15 (+2.02%)
Pharma & Biotech ETFs at One-Month High: Here's Why

Pharma and biotech ETFs are in great shape and are trading at a one-month high level.

CNCR : 15.18 (+3.69%)
BBC : 25.34 (+3.34%)
PJP : 73.91 (+2.20%)
XPH : 41.39 (+2.12%)
PBE : 60.96 (+1.68%)
IEIH : 34.13 (unch)
GNOM : 13.07 (+3.90%)
GERM : 21.65 (+2.91%)
IBBQ : 19.61 (+2.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Loncar Cancer Immunotherapy ETF seeks investment results that correspond generally to the price and yield per for mance, before fees and expenses, of the Loncar Cancer Immunotherapy Index.

See More

Key Turning Points

3rd Resistance Point 14.64
2nd Resistance Point 14.64
1st Resistance Point 14.64
Last Price 15.18
1st Support Level 14.63
2nd Support Level 14.63
3rd Support Level 14.63

See More

52-Week High 30.49
Fibonacci 61.8% 23.72
Fibonacci 50% 21.63
Fibonacci 38.2% 19.53
Last Price 15.18
52-Week Low 12.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar